Freenome, Inc.
FRNM
Get informed when a big investor buys or sells
+ FollowMarket Cap$124.44M
Close$
Share Statistics
| Market cap | $124.44 Million |
|---|---|
| Enterprise Value | $124.00 Million |
| Dividend Yield | $NaN (NaN%) |
| Earnings per Share | $- |
| Beta | - |
| Outstanding Shares | - |
Return
| Return on Equity | 12.11% |
|---|---|
| Return on Assets | -0.89% |
| Return on Invested Capital | -4.26% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 150.06 |
| Enterprise Value to EBIT | -35.38 |
| Enterprise Value to Net Income | -163 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 15, 2026
EPS Estimate
$-1.77
Average shareholder expectationRevenue Estimate
$3.02 M
Average shareholder expectationNext Earnings Call
Expected Date
December 2, 2026
EPS Estimate
$0.14
Average shareholder expectationRevenue Estimate
$84.94 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Perceptive Capital Solutions Corp
378 employees
CEO: Aaron Elliott Freenome is an early cancer detection company developing blood-based screening tests to identify cancer in its earliest, most treatable stages. The company's proprietary multiomics discovery platform analyzes circulating cell-free DNA me...